- £5.62bn
- £7.15bn
- £22.20bn
- 87
- 64
- 87
- 95
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15,227 | 14,755 | 13,412 | 17,732 | 22,205 |
Cost of Revenue | |||||
Gross Profit | 1,638 | 1,740 | 1,819 | 2,038 | 2,405 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 14,858 | 14,389 | 12,990 | 17,274 | 21,693 |
Operating Profit | 369 | 367 | 423 | 458 | 512 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 327 | 311 | 365 | 406 | 432 |
Provision for Income Taxes | |||||
Net Income After Taxes | 271 | 254 | 303 | 326 | 347 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 263 | 246 | 293 | 312 | 334 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 263 | 246 | 293 | 312 | 334 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.07 | 3.13 | 3.36 | 3.58 | 3.61 |
Dividends per Share |